ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Knee"

  • Abstract Number: 950 • 2015 ACR/ARHP Annual Meeting

    In a Two-Year Double-Blind Randomized Controlled Multicenter Study, Chondroitin Sulfate Was Significantly Superior to Celecoxib at Reducing Cartilage Loss with Similar Efficacy at Reducing Disease Symptoms in Knee Osteoarthritis Patients

    Jean-Pierre Pelletier1, Jean Pierre Raynauld2, André Beaulieu3, Louis Bessette4, Frédéric Morin5, Artur J Fernandes6, François Abram7, Marc Dorais8 and Johanne Martel-Pelletier9, 1Rheumatology, Institut de recherche en rhumatologie de Montréal (IRRM), Montréal, QC, Canada, 2Osteoarthritis Research Unit, CRCHUM, Montreal, Montreal, QC, Canada, 3Centre de rhumatologie St-Louis, St. Louis, QC, Canada, 4Groupe de Recherche en Rhumatologie et Maladies Osseuses, Quebec, Quebec, QC, Canada, 5Centre de Recherche Musculo-squelettique, Trois-Rivières, Trois-Rivières, QC, Canada, 6Centre de Recherche Musculo-squelettique, Trois-Rivières, 6Rheumatology Division, Sherbrooke, Sherbrooke, QC, Canada, 7Medical Imaging Research & Development, ArthroLab Inc, Montreal, QC, Canada, 8StatSciences Inc., Montreal, Canada, Montreal, QC, Canada, 9Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM),, Montreal, QC, Canada

    Background/Purpose: In osteoarthritis (OA) treatment, although chondroitin sulfate (CS) was found in a number of studies using radiography to have a structure modifying effect, to…
  • Abstract Number: 2248 • 2015 ACR/ARHP Annual Meeting

    Knee Pain Burden Is Associated with Decreased Motor Performance: Data from the Osteoarthritis Initiative

    Javad Razjouyan1, Bijan Najafi2, Erin Ashbeck3, Dorothy D. Dunlop4, Julia (Jungwha) Lee5, Lynn Hamilton3 and C. Kent Kwoh6, 1Consortium on Advanced Motion Performance (iCAMP), Department of Surgery, University of Arizona, Tucson, AZ, 2Department of Surgery and Department of Biomedical Engineering, University of Arizona, Tucson, AZ, 3Arthritis Center, University of Arizona, Tucson, AZ, 4Institute for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Department of Preventive Medicine, Biostatistics Collaboration Center, Northwestern University Feinberg School of Medicine, Chicago, IL, 6Rheumatology, University of Arizona, Tucson, AZ

    Background/Purpose: Knee pain is the presenting symptom in knee osteoarthritis (OA), but the impact of knee pain burden in OA has been understudied. We examined…
  • Abstract Number: 2861 • 2014 ACR/ARHP Annual Meeting

    Changes in Knee Kinematics from a 6-Week Hip and Trunk Strengthening Program for Persons with Patellofemoral Osteoarthritis

    Lisa Hoglund1, Laura Pontiggia2, John Kelly IV3, Mark Arnott4, Olumide Babalola4, Andrew Gushen4 and James Carey3, 1Department of Physical Therapy, University of the Sciences, Philadelphia, PA, 2Mathematics, Physics, and Statistics, University of the Sciences, Philadelphia, PA, 3Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, 4Physical Therapy, University of the Sciences, Philadelphia, PA

    Background/Purpose: Patellofemoral (PF) osteoarthritis (OA) is prevalent in middle-aged adults. Aberrant lower extremity (LE) biomechanics is one etiology of knee OA. Reduced peak knee flexion…
  • Abstract Number: 1280 • 2014 ACR/ARHP Annual Meeting

    Relationship of Buckling and Knee Injury to Pain Exacerbation in Knee Osteoarthritis: A Web-Based Case-Crossover Stud

    Isabelle Zobel1,2, Tahereh Erfani3, Kim Bennell4, Joanna Makovey3, Ben Metcalf4, Jian Sheng Chen5, Lyn March3, Yuqing Zhang6, Felix Eckstein7 and David J. Hunter3, 1Institute of Anatomy, Paracelsus Medical University Salzburg, Salzburg, Austria, 2Institute of Bone and Joint Research, Kolling Institute, University of Sydney, St Leonards, Australia, 3Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, 4University of Melbourne, Melbourne, Australia, 5Rheumatology Royal North Shore Hospital, University of Sydney Institute of Bone and Joint Research, St Leonards, Australia, 6Boston University School of Medicine, Boston, MA, 7Anatomy & Musculoskeletal Research, Paracelsus Medical University, Salzburg, Austria

    Background/Purpose Knee osteoarthritis (OA) pain is neither constant nor stable and exacerbations of pain are disabling. We examined whether knee injury and buckling (giving way)…
  • Abstract Number: 213 • 2014 ACR/ARHP Annual Meeting

    Foot Center of Pressure in Knee Osteoarthritis (OA) and Its Association with Knee Load Reduction with Barefoot Walking

    Christopher Ferrigno1, Roy H. Lidtke2, Markus Wimmer3, Anjali Nair2, Laura E. Thorp4, Louis F. Fogg5, Joel A. Block6 and Najia Shakoor6, 1Department of Anatomy and Cell Biology, Rush University Medical Center, Chicago, IL, 2Section of Rheumatology, Rush University Medical Center, Chicago, IL, 3Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 4Anatomy and Cell Biology, Rush University Medical Center, Chicago, IL, 5Department of Nursing, Rush University Medical Center, Chicago, IL, 6Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Biomechanical factors including excessive knee loading have been shown to be important in the pathophysiology, severity and progression of knee osteoarthritis (OA).  Several biomechanical…
  • Abstract Number: 2437 • 2014 ACR/ARHP Annual Meeting

    Why Doesn’t Participation in Activity Increase Following Hip or Knee Replacement?

    Aileen Davis1, Viji Venkataramanan1, Jessica Bytautas2, Rose Wong1, Lisa Carlesso1, Anthony Perruccio3 and Fiona Webster2, 1Division of Health Care & Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 2Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada, 3Toronto Western Hospital, University Health Network, Toronto, ON, Canada

    Background/Purpose Activity is critical for healthy aging. Our prior work demonstrated that despite improved pain and function, people did not increase their participation in activity…
  • Abstract Number: 1191 • 2014 ACR/ARHP Annual Meeting

    The Kimriss Bone Marrow Lesion Score in Patients with Osteoarthritis of the Knee Correlates with WOMAC Pain Status Using Target-Lesion Based Scoring Methodology; Data from the Osteoarthritis Initiative

    David McDougall1, Jacob Jaremko1, RG Lambert1 and Walter P. Maksymowych2, 1Radiology, University of Alberta, Edmonton, AB, Canada, 2Medicine/Rheumatic Dis Unit, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Inflammatory components of osteoarthritis including bone marrow lesions (BML) may be a target for therapy.  Limited literature quantifies the relation of these markers on…
  • Abstract Number: 212 • 2014 ACR/ARHP Annual Meeting

    Relation of Shoe Stability to Risk of Knee Cartilage Damage: The Multicenter Osteoarthritis Study

    K. Douglas Gross1,2, Howard J. Hillstrom3, Jingbo Niu4, Michael C. Nevitt5, James C. Torner6, Cora E. Lewis7 and David T. Felson2, 1Physical Therapy, MGH Institute of Health Professions, Boston, MA, 2Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 3Rehabilitation, Hospital Special Surgery (HSS), New York, NY, 4Clinical Epidemiology Research and Training Unit, Boston University, Boston, MA, 5Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 6Epidemiology, University of Iowa, Iowa City, Iowa City, IA, 7Preventive Medicine, The University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Clinical guidelines recommend that “every patient with knee osteoarthritis should receive advice concerning appropriate footwear”, yet the recommended content of this advice is not…
  • Abstract Number: 2353 • 2014 ACR/ARHP Annual Meeting

    The Nitric Oxide Receptor Soluble Guanylyl Cyclase Is Found in Lymphatic Vessels of Arthritic Mice and Inhibition Alters Lymphatic Pulse

    Homaira Rahimi1, Yawen Ju2, Echoe M. Bouta3, Ronald Wood4, Christopher T. Ritchlin5 and Edward M. Schwarz6, 1Rheumatology, University of Rochester/Golisano Children's Hospit, Rochester, NY, 2Univ of Rochester Med Ctr, University of Rochester, Rochester, NY, 3University of Rochester School of Medicine and Dentistry, Rochester, NY, 4Department of Urology, University of Rochester Medical Center, Rochester, NY, 5Allergy Immunology & Rheumatology, University of Rochester Medical Center, Rochester, NY, 6Center for Musculoskeletal Research, University of Rochester, Rochester, NY

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic erosive inflammatory condition that is characterized by episodes of “flare” due to synovitis of an affected joint. It…
  • Abstract Number: 1087 • 2014 ACR/ARHP Annual Meeting

    The Prevalence of Knee Arthritis and Associated Self-Reported Limitation of Activity in Chinese Populations

    Xu Tang Sr., Ke TAO, Qiang LIU, Xu Wu, Zheng Ming Cao and Jian Hao Lin, Arthritis Institute, People’s Hospital, Peking University, Beijing, China

    Background/Purpose To estimate the prevalence of knee arthritis and assess the association between knee arthritis and self-reported limitation of activity in Chinese Populations. Methods Populations:…
  • Abstract Number: 195 • 2014 ACR/ARHP Annual Meeting

    Dependence on Walking Aids and Patient-Reported Outcomes after Total Knee Arthroplasty

    Jasvinder A. Singh1 and David Lewallen2, 1University of Alabama and VA Medical Center, Birmingham, AL, 2Orthopedics, Mayo Clinic college of medicine, Rochester, MN

    Background/Purpose: To examine whether function and pain outcomes of patients undergoing primary total knee arthroplasty (TKA) are changing over time.Methods: The Mayo Clinic Total Joint…
  • Abstract Number: 2231 • 2014 ACR/ARHP Annual Meeting

    Combined Chondroitin Sulfate and Glucosamine Is Comparable to Celecoxib for Painful Knee Osteoarthritis. Results from a Multicenter, Randomized, Double-Blind, PHASE IV NON-Inferiority TRIAL 

    Marc Hochberg1, Johanne Martel-Pelletier2, Jordi Monfort3, Ingrid Moller4, Juan Ramon Castillo5, Nigel K. Arden6,7,8, Francis Berenbaum9,10, Jean-Pierre Pelletier11, Francisco J. Blanco12, Philip G. Conaghan13, Yves Henrotin14,15, Thomas Pap16, Pascal Richette17,18,19, Allen Sawitzke20, Patrick du Souich21 and Moves Investigation Group22, 1University of Maryland School of Medicine, Baltimore, MD, 2Osteoarthritis Research Unit CR-CHUM, Notre-Dame Hospital 1560 Sherbrooke St East, Montreal, QC, Canada, 3Department of Rheumatology, Grup de recerca cel•lular en inflamació i cartílag. IMIM (Institut de Recerca Hospital del Mar), Barcelona, Spain, 4Instituto Poal, Barcelona, Spain, 5Head of Clinical Pharmacology Unit Hospital Universitario Virgen del Rocío, Sevilla, Spain;, Sevilla, Spain, 6NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom, 7Arthritis Research UK (ARUK), Center for Sports, Exercise and Osteoarthritis, University of Oxford, Nuffield Orthopaedic Centre, Oxford, United Kingdom, 8MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom, 9Sorbonne University, INSERM UMR S938, UPMC, University of Paris 06, DHU i2B, Paris, France, 10Department of Rheumatology, Assistance Publique – Hôpitaux de Paris, Saint-Antoine Hospital, Paris, France, 11Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital, Montreal, QC, Canada, 12Rheumatology Service, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain, 13University of Leeds, Leeds, United Kingdom, 14Physical Therapy and Rehabilitation Department, Princess Paola Hospital, Marche-en-Famenne, Belgium, 15Bone and Cartilage Research Unit, Arthropôle Liège, University of Liège, Institute of Pathology, CHU Sart-Tilman, Liege, Belgium, 16Institute of Experimental Muskuloskeletal Medicine University Hospital Münster, Münster, Germany, 17Université Paris Diderot, UFR médicale, Paris, France, 18INSERM 1132, Université Paris-Diderot, Hôpital Lariboisière, Paris, France, 192 Rue Ambroise Pare, Hopital Lariboisiere, Paris, France, 20Rheumatology, University of Utah Medical Center, Salt Lake City, UT, 21Department of Pharmacology, Faculty of Medicine, University of Montreal, Montreal, QC, Canada, 22Spain, Germany, France and Poland, Barcelona, Spain

    Background/Purpose The Multicentre Osteoarthritis interVEntion trial with Sysadoa (MOVES) compared efficacy and safety of Chondroitin sulfate (CS) and Glucosamine Hydrochloride (GH) with that of Celecoxib…
  • Abstract Number: 1024 • 2014 ACR/ARHP Annual Meeting

    Racial Differences in Biochemical Knee Cartilage Composition Between African American and Caucasian American Women with MR-Based T2 Relaxation Time Measurements – Data from the Osteoarthritis Initiative

    Martin Kretzschmar1, Ursula Heilmeier2, Aihong Yu3, Gabby B. Joseph4, Felix Liu5, Hans Liebl3, Charles E. McChulloch6, Michael C. Nevitt7, Nancy E. Lane8 and Thomas M Link9, 1Musculoskeletal and Quantitative Imaging Research Group, Department of Radiology & Biomedical Imaging,, University of California, San Francisco, San Francisco, CA, 2Department of Radiology & Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, UCSF, San Francisco, CA, 3Musculoskeletal and Quantitative Imaging Research Group, Department of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, CA, 4Musculoskeletal and Quantitative Imaging Research Group, Department of Radiology & Biomedical Imaging, University of California San Francisco, San FRancisco, CA, 5University of California at San Francisco, San Francisco, CA, 6Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, 7Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 8Internal Medicine, Center for Musculoskeletal Health, UC Davis School of Medicine, Sacramento, CA, 9Department of Radiology and Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, UCSF, San Francisco, CA

    Background/Purpose: To determine whether knee cartilage composition differs between African-American and matched Caucasian-American women at risk for Osteoarthitis (OA) using in-vivo 3T MRI T2 relaxation…
  • Abstract Number: 66 • 2014 ACR/ARHP Annual Meeting

    Association of Knee Osteoarthritis and Limitations in Physical Function in a Rural Chinese Population: The Wuchuan OA Study

    Xu Wu1, Jingbo Niu2, Yan Ke3, Qiang LIU4, Xu Tang Sr.5, Zhengming Cao3, Rujun Li3, Hu Li3, Kai Wang3, Xin Zhi3, Daniel White6 and Jian Hao Lin5, 1Peking University People's Hospital Arthritis Clinic & Research Center, Peking University Health Science Center, Beijing, China, 2Clinical Epidemiology Research and Training Unit, Boston University, Boston, MA, 3Peking University People’s Hospital, Beijing, China, 4Arthritis Clinical and Reserch Center, Peking University People's Hospital, Peking University Health Science Center, Beijing, China, 5Peking University Health Science Center, Beijing, China, 6Clinical Epidemiology Training, Boston Univ School of Med, Boston, MA

    Background/Purpose knee osteoarthritis (OA) causes more limitations in physical function than other chronic conditions in Caucasians.  Knee OA is known to be more prevalent among…
  • Abstract Number: 2238 • 2014 ACR/ARHP Annual Meeting

    Exploratory Six Month Phase IIa Study of a Potential Disease Modifying Drug in Patients with OA of the Knee

    Ketan Desai, Voltarra Pharma, Easton, PA

    Background/Purpose: No disease modifying drugs exists to treat osteoarthritis.  Recently, a phase II study from Tasmania showed that Zoledronic Acid, a bisphosphonate, has an effect…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 24
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology